Caeregen Therapeutics

Caeregen Therapeutics is a regenerative medicine company developing treatments for neurosensory disorders. By leveraging biological pathways and signaling associated with cell and organ development, Caeregen is committed to developing targeted therapies that can repair, restore, and protect neurosensory tissues affected by genetic or acquired diseases. Caeregen is currently developing Noregen, a unique, novel, recombinant human Norrin-derived growth factor protein mimetic, for the potential treatment of retina-related vision loss.